Congressmen Applaud VA’s Research on Psychedelic Treatment for PTSD and Depression in Veterans

Representatives Lou Correa and Jack Bergman support the VA’s request for study recommendations on psychedelics for veterans with PTSD and depression. This decision follows years of advocating for novel mental health treatments like psychedelics for veterans and service members.

Can Psychedelic cure PTSD and Depression? (Photo: Google)

Representatives Correa and Bergman, co-chairs of the Psychedelics Advancing Therapies (PATH) Caucus, have long supported a federal study on psychedelic drugs to treat veterans’ unseen wounds.

These therapies claim to treat mental health difficulties with up to 80% effectiveness, making them one of the most breakthrough developments in almost fifty years.

The House included the Correa-Bergman Amendment last year in federal budget legislation, urging the VA to conduct “large-scale studies” on breakthrough drugs like psilocybin and MDMA. Lawmakers plan to battle for universal access to these life-saving therapies.

READ ALSO: Bridgeport School Superintendent Unveils Mental Health Initiative

The VA’s request for applications (RFA) for proposals from its network of VA researchers marks a monumental moment in the effort to explore the use of psychedelic compounds in treating PTSD and depression in veterans.

The announcement has been hailed as a significant step forward in addressing the mental health crisis and advancing therapies that could potentially cure veterans of their invisible wounds.

Congressmen Correa and Bergman continue to ensure these therapies are available to service members and veterans in need.

READ ALSO: U.S. Lawmakers Consider Medicaid Funding For Mental Health Institutions In Response To Escalating Drug Crisis